Vascular endothelial growth factor single-nucleotide polymorphism in gall bladder cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 10, 2013, Pages 1678-1685

  Mishra, Kumudesh ^a   Behari, Anu ^a   Kapoor, Vinay Kumar ^a   Khan, M Salman ^b   Prakash, Swayam ^a   Agrawal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INTEGRAL UNIVERSITY   (India)

Author keywords

Chronic cholecystitis; Gallbladder cancer; VEGF; Xanthogranulomatous cholecystitis

Indexed keywords

VASCULOTROPIN;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DRIFT; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CHRONIC CHOLECYSTITIS; GALLBLADDER CANCER; VEGF; XANTHOGRANULOMATOUS CHOLECYSTITIS;

CHOLECYSTITIS; CHRONIC DISEASE; FEMALE; GALLBLADDER NEOPLASMS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRANULOMA; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XANTHOMATOSIS;

EID: 84897596415     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12343     Document Type: Article

References (40)

1. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75: 171-190.
2. Kapoor VK, McMichael AJ. Gallbladder cancer: an "Indian" disease. Natl Med. J. India 2003; 16: 209-213.
3. Indian Council of Medical Research. National Cancer Registry Programme. Consolidated report of the population based cancer registries 1990-1996. Incidence and distribution of cancer. Indian Council of Medical Research New Delhi 2001; 53.
4. Krishnani N, Dhingra S, Kapoor S, Pandey R. Cytopathologic diagnosis of xanthogranulomatous-cholecystitis and coexistent lesions. A prospective study of 31 cases. Acta Cytol. 2007; 51: 37-41.
5. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 2002; 29: 15-18.
6. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003; 9: 653-660.
7. Shahbazi M, Fryer AA, Pravica V etal. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2002; 13: 260-264.
8. Uthra S, Raman R, Mukesh BN etal. Association of VEGF gene polymorphisms with diabetic retinopathy in a South Indian cohort. Ophthalmic Genet. 2008; 29: 11-15.
9. Prior SJ, Hagberg JM, Paton CM etal. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am. J. Physiol. Heart Circ. Physiol. 2006; 290: 1848-1855.
10. Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol. Dial. Transplant. 2007; 22: 827-832.
11. Papazoglou D, Galazios G, Koukourakis MI etal. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol. Hum. Reprod. 2004; 10: 321-324.
12. Bae SJ, Ahn DH, Hong SP etal. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and patients with stomach cancer. Yonsei Med. J. 2008; 49: 783-791.
13. Bradbury PA, Zhai R, Ma C etal. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. Clin. Cancer Res. 2009; 15: 4680-4685.
14. Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res. 2008; 28 (2B): 1271-1276.
15. Hofmann G, Langsenlehner U, Renner W etal. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J. Cancer Res. Clin. Oncol. 2008; 134: 591-595.
16. Chae YS, Kim JG, Sohn SK etal. Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J. Korean Med. Sci. 2008; 23: 421-427.
17. Dassoulas K, Gazouli M, Rizos S etal. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol. Carcinog. 2009; 48: 563-569.
18. Hsing AW, Sakoda LC, Rashid A etal. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res. 2008; 68: 6442-6452.
19. Aggarwal S, Parveen F, Faridi RM, Phadke S, Borkar M, Agrawal S. Vascular endothelial growth factor gene polymorphisms in North Indian patients with recurrent miscarriages. Reprod. Biomed. Online 2011; 22: 59-64.
20. Prakash S, Prasad N, Sharma RK, Faridi RM, Agrawal S. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease. Cytokine 2012; 58: 261-266.
21. Papazoglou D, Galazios G, Papatheodorou K etal. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil. Steril. 2005; 83: 959-963.
22. Jain L, Vargo CA, Danesi R etal. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol. Cancer Ther. 2009; 8: 2496-2508.
23. Tian Y, Ding RY, Zhi YH, Guo RX, Wu SD. Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma determination of tumor vascularity. World J. Gastroenterol. 2006; 12: 415-419.
24. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2002; 2: 795-803.
25. Ferrara N, Geber HP, Le Couter J. The biology of VEGF and its receptors. Nat. Med. 2003; 9: 669-676.
26. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 2004; 46: 293-298.
27. Ozdemir F, Akdogan R, Aydin F etal. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer. J. Exp. Clin. Cancer Res. 2006; 25: 83-88.
28. Kim JG, Chae YS, Sohn SK etal. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Clin. Cancer Res. 2008; 14: 62-66.
29. Brown LF, Berse B, Jackman RW etal. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adeno-carcinomas of the gastrointestinal tract. Cancer Res. 1993; 53: 4727-4735.
30. McCarron SL, Edwards S, Philip R. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 2002; 6: 3369-3372.
31. Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun. 2002; 3: 229-232.
32. Park MH, Hong HS, Kim WJ, Doyeun O, Hwang GS. Gender-specific Association of the VEGF -2578C>A. Polymorphism in Korean Patients with Colon Cancer. Anticancer Res. 2007; 27 (5b): 2535-2540.
33. Kataoka N, Cai Q, Wen W etal. Population based case-control study of VEGF gene polymorphism and breast cancer risk among Chinese women. Cancer Epidemiol. Biomarkers Prev. 2006; 15: 1148-1152.
34. Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L. Association of VEGF genetic polymorphism with prostate carcinoma risk and clinical outcome. Cytokine 2006; 35: 21-28.
35. Krippl P, Langsenlehner U, Renner W etal. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int. J. Cancer 2003; 106: 468-471.
36. Jin Q, Hemminki K, Enquist K etal. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin. Cancer Res. 2005; 11: 3647-3653.
37. Jacobs EJ, Feigelson HS, Bain EB etal. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res. 2006; 8: R22.
38. Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int. J. Cancer 2007; 121: 1009-1016.
39. Jakubowska A, Gronwald J, Menkiszak J etal. The VEGF 936C>T 3′UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett. 2008; 262: 71-76.
40. Zhai R, Liu G, Zhou W etal. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clin. Cancer Res. 2008; 14: 612-617.